I-Amoxiclav iyisisombululo sokuxhatshazwa se-antibacterial equkethe i-amoxicillin i-trihydrates kunye ne-clavulanic acid kwisilinganiso se-4: 1 (kuphela kwisilinganiselo sokumiswa kudla ngo-7: 1).
I-Amoxicillin i-trihydrate yindlela yokulwa ne - antibiotic ebanzi, kunye ne-acoustic clavulanic yi-inhibitor ye-enzymes eyenza i-microorganism, ukuze i-amoxicillin ingabhubhisi. Isichengisiso sithinteka ngokugqithiseleyo kumathambo, sisasaza igazi kuzo zonke izitho kwaye sitshintshwe ngokungatshintshiyo neentso, asingene ngaphakathi kwinqanaba legazi, kodwa lingena kwi-barrier barrier.
Iinkcazo kunye nokuchasene nezilwanyana
Ngokubhekiselele kwezinye iziza-antibiotics, izibonakaliso eziphambili ze-Amoxiclav ziinkqubo zokuvutha zendawo ezahlukileyo. Isilwanyana siphuculelwe xa:
- iinkqubo ezinzima kunye ezingapheliyo zokuphefumula kwiphepha eliphezulu lokuphefumula;
- Ukuqhaqhaqhaqhaqhaqatha okungapheliyo kwesikhumba kunye nezicubu ezithambileyo;
- izifo ezinzima kunye nezifo ezingapheliyo ze-bronchi kunye nemiphunga;
- iingxaki zeentso kunye nesibhanxa;
- ukusuleleka kwethambo kunye nezicubu ezixhumeneyo;
- odontogenic (ezinxulumene namazinyo) iinkqubo zokuvuvukala;
- izifo zesondlo sesisu;
- ukwenzela ukuthintela kunye unyango lweengxaki zokuhamba emva kokusebenza;
- iinkqubo zokuvuvukala kwimizimba yobunzima.
Ukungqinelana kweAmoxiclav:
- i-hypersensitive to the drug or components thereof;
- ukwandiswa kobubele kwi antibiotics penicillin, cephalosporin;
- i-lymphocytic leukemia kunye ne-infectous mononucleosis;
- izifo zesibindi ezibangelwa yiziyobisi kwi-anamnesis (i-jailcetic cholestatic, hepatitis).
Amoxiclav ngexesha lokukhulelwa - umyalelo
Abaphuhlisi besibango samachiza ukuba baqhuba izifundo malunga nabafazi abakhulelweyo abathatha i-Amoxiclav ngexesha lokukhulelwa, kunye nakwi-trimester yokuqala (iiveki ezi-12 zokuqala) kwaye akukho miphumo engathandwayo kwimfusane efunyenwe. Kwaye isilwayo ngokwawo asiphikisana nokukhulelwa, kwaye ukuhlolwa kwabo batywala i-Amoxiclav ngexesha lokukhulelwa kulungile.
Kodwa inyaniso kukuba enye yeengxenye zeliyobisi yi-antixictic amoxicillin, evela kwiqela le-penisillis penticillin, kwaye ingena kwi-barrier barrier. Ngokumalunga ne-teratogenic (i-mutagenic, inxaxheba ekuphuhliseni ukungaphumeleli komntwana ), isenzo se-antibiotiki zolu chungechunge lweengcamango sisabonakalisa, kodwa kungcono ukuphepha ukusetyenziswa kweziyobisi kwiiveki zokuqala ezi-5-7 zokukhulelwa. Kwaye kwinqanaba lesibini neyesithathu, i-amoxicillin iboniswe ukuba ikhuselekile kumntwana kwaye ihlala ichongiwe unyango lweentlobo ezahlukeneyo zokusuleleka.
Kodwa ngokwecandelo lesibini leziyobisi kunolwazi oluthile, kwaye ngoko ke isilwanyana sidla ngokutshintshwa ngeendlela ezingapheliyo zokukhululwa kwe-amoxicillin. Kodwa i-Amoxiclav, enganyangekiyo kwii-microorganisms, ineempembelelo ezimbalwa kwaye ibulela ngokugqithiseleyo kwi-acoustic clavulanic, ngoko ke ugqirha kuphela unokukhetha nokutshintsha isigulo ukuze aphathe isifo.
Amoxiclav ngexesha lokukhulelwa - umyinge
Umlinganiselo wesilwanyana kubafazi abasetyhini ahlukanga kwinto eqhelekileyo kwaye kuxhomekeke kuphela kwisibandezelo sesi sifo. Ekubeni inani le-clavulanic acid kwiiphilisi ze-Amoxiclav zifana (125 mg), kuphela umthamo we-amoxicillin ubalwa. Ngokukhanya kunye naphakathi
Ngokuxhomekeke kwidaysi yansuku zonke kunye nendlela yokukhululwa kweziyobisi, unokubala ukuba zininzi kwaye ziphi iipilisi ezifunekayo ukuba ukhulelwe. Ngokomzekelo, i-Amoxiclav 1000 ekukhulelweni isetyenziselwa i-tablet 1 ekuseni kwaye kusihlwa, ukuba umlinganiselo weliyobisi u--1000 mg 2 i-rza ngosuku, i-drug Amoxiclav 625 kule meko, kufuneka uphuze amacwecwe a-2 (iipilisi ezine ngosuku), okungekho ngokufanelekileyo. Isilwanyana se-Amoxiclav 625 ekukhulelweni sisetyenziswe xa umlinganiselo weliyobisi unama-500 mg nganye iiyure eziyi-8. Kuthathwa 1 tablet nganye kwiiyure eziyi-8, okanye sebenzisa iipilisi ezi-½ ezineeritha ezili-1000 mg. Isilwanyana singcono ukuthatha, ukuchithwa kwi-100 ml yamanzi ngaphambi kokutya, inkqubo yokonyango - iintsuku ezingama-5-7.